BioVie Inc. Financing Receivable, after Allowance for Credit Loss
BioVie Inc. (BIVI) had Financing Receivable, after Allowance for Credit Loss of -$250.00 thousand as of 2018-06-30, per its 10-K filed 2018-10-05.
Discontinued › Balance Sheet › Assets
us-gaap:NotesReceivableNet · last filed 2018-10-05
- 2018-06-30: Financing Receivable, after Allowance for Credit Loss -$250.00K.
| Period end | Financing Receivable, after Allowance for Credit Loss |
|---|---|
| 2018-06-30 | -$250.00K 10-K · filed 2018-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |